StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics cash

Cash and short-term investments held at the end of each period.

NeoGenomics's cash was $139.28M at Sep 30, 2026. For fiscal 2025 it was $159.62M, down 56.5% from the year before. Over ten years it grew 21.2% a year on average. The highest annual figure on record is $515.39M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$159.62M-56.5%
FY2024Dec 31, 2024$367.01M+7.2%
FY2023Dec 31, 2023$342.49M+30.1%
FY2022Dec 31, 2022$263.18M-48.9%
FY2021Dec 31, 2021$515.39M+62.0%
FY2020Dec 31, 2020$318.18M+83.9%
FY2019Dec 31, 2019$173.02M+1663.5%
FY2018Dec 31, 2018$9.81M-23.5%
FY2017Dec 31, 2017$12.82M+2.4%
FY2016Dec 31, 2016$12.53M-46.5%
FY2015Dec 31, 2015$23.42M-30.5%
FY2014Dec 31, 2014$33.69M+596.9%
FY2013Dec 31, 2013$4.83M+158.8%
FY2012Dec 31, 2012$1.87M-28.9%
FY2011Dec 31, 2011$2.63M+139.6%
FY2010Dec 31, 2010$1.10M-32.7%
FY2009Dec 31, 2009$1.63M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$139.28M-15.1%
Q2 FY2026Jun 30, 2026$145.54M-5.9%
Q1 FY2026Mar 31, 2026$146.14M-57.8%
Q4 FY2025Dec 31, 2025$159.62M-56.5%
Q3 FY2025Sep 30, 2025$164.12M-54.7%
Q2 FY2025Jun 30, 2025$154.72M-56.4%
Q1 FY2025Mar 31, 2025$346.19M+4.3%
Q4 FY2024Dec 31, 2024$367.01M+7.2%
Q3 FY2024Sep 30, 2024$361.99M+18.2%
Q2 FY2024Jun 30, 2024$355.09M+22.8%
Q1 FY2024Mar 31, 2024$331.91M+20.4%
Q4 FY2023Dec 31, 2023$342.49M+30.1%
Q3 FY2023Sep 30, 2023$306.24M+15.1%
Q2 FY2023Jun 30, 2023$289.07M-38.0%
Q1 FY2023Mar 31, 2023$275.61M-42.8%
Q4 FY2022Dec 31, 2022$263.18M-48.9%
Q3 FY2022Sep 30, 2022$266.13M-51.0%
Q2 FY2022Jun 30, 2022$465.95M-18.5%
Q1 FY2022Mar 31, 2022$481.43M-40.0%
Q4 FY2021Dec 31, 2021$515.39M+62.0%
Q3 FY2021Sep 30, 2021$542.71M+91.4%
Q2 FY2021Jun 30, 2021$571.75M+93.6%
Q1 FY2021Mar 31, 2021$802.68M+830.6%
Q4 FY2020Dec 31, 2020$318.18M+83.9%
Q3 FY2020Sep 30, 2020$283.61M+58.5%
Q2 FY2020Jun 30, 2020$295.28M+76.4%
Q1 FY2020Mar 31, 2020$86.25M+553.7%
Q4 FY2019Dec 31, 2019$173.02M+1663.5%
Q3 FY2019Sep 30, 2019$178.89M+51.0%
Q2 FY2019Jun 30, 2019$167.44M+1674.6%
Q1 FY2019Mar 31, 2019$13.20M-13.0%
Q4 FY2018Dec 31, 2018$9.81M-23.5%
Q3 FY2018Sep 30, 2018$118.44M+869.9%
Q2 FY2018Jun 30, 2018$9.44M-13.7%
Q1 FY2018Mar 31, 2018$15.17M+37.5%
Q4 FY2017Dec 31, 2017$12.82M+2.4%
Q3 FY2017Sep 30, 2017$12.21M–
Q2 FY2017Jun 30, 2017$10.93M–
Q1 FY2017Mar 31, 2017$11.04M–
Q4 FY2016Dec 31, 2016$12.53M–

More NeoGenomics figures

See a number that looks wrong?